4th Department of Pediatrics, Faculty of Medicine, Aristotle University of Thessaloniki, Papageorgiou General Hospital, 564 03 Thessaloniki, Greece.
Metabolism. 2012 Apr;61(4):562-8. doi: 10.1016/j.metabol.2011.09.004. Epub 2011 Oct 27.
YKL-40 (chitinase 3-like protein 1) is a newly recognized protein that is secreted by activated macrophages and neutrophils and expressed in a broad spectrum of inflammatory conditions and cancers. It has also been associated with endothelial dysfunction and diabetes in adults. Its role in childhood obesity has not been evaluated yet. Our aim was to evaluate the associations of serum YKL-40 levels with markers of obesity, inflammation, and insulin resistance in children. Forty-one obese prepubertal children and 41 age- and sex-matched lean controls were included, and serum YKL-40 levels were determined. Body mass index (BMI), blood pressure (BP), body fat percentage, fasting glucose, insulin, homeostasis model assessment for insulin resistance (HOMA-IR) index, whole-body insulin sensitivity index, lipids, white blood cell (WBC) count, C-reactive protein, and fibrinogen levels were also assessed. Obese children had higher YKL-40 levels compared with controls (P = .003). Insulin-resistant individuals showed higher YKL-40 compared with non-insulin-resistant individuals after adjusting for age and BMI (adjusted P = .039). Serum YKL-40 levels were positively correlated with age, BMI, body fat percentage, fasting glucose and insulin, HOMA-IR index, whole-body insulin sensitivity index, systolic BP, mean BP, and WBC count (P < .05). After adjustment for age, sex, BMI, WBC count, and systolic BP, HOMA-IR index remained significantly associated with YKL-40 levels (P < .001). The study suggests that YKL-40 levels are elevated in obese youth and represent a marker of insulin resistance even in childhood. Prospective studies are needed to determine whether children with elevated YKL-40 levels are at higher risk for future cardiovascular disease.
YKL-40(几丁质酶 3 样蛋白 1)是一种新发现的蛋白,由活化的巨噬细胞和中性粒细胞分泌,并在广泛的炎症和癌症情况下表达。它也与成人的内皮功能障碍和糖尿病有关。但其在儿童肥胖中的作用尚未得到评估。我们的目的是评估血清 YKL-40 水平与肥胖、炎症和胰岛素抵抗标志物在儿童中的相关性。纳入 41 名肥胖青春期前儿童和 41 名年龄和性别匹配的瘦对照组,并测定血清 YKL-40 水平。还评估了体重指数(BMI)、血压(BP)、体脂肪百分比、空腹血糖、胰岛素、胰岛素抵抗评估的稳态模型(HOMA-IR)指数、全身胰岛素敏感性指数、血脂、白细胞(WBC)计数、C 反应蛋白和纤维蛋白原水平。肥胖儿童的 YKL-40 水平高于对照组(P=0.003)。调整年龄和 BMI 后,胰岛素抵抗者的 YKL-40 水平高于非胰岛素抵抗者(调整后 P=0.039)。血清 YKL-40 水平与年龄、BMI、体脂肪百分比、空腹血糖和胰岛素、HOMA-IR 指数、全身胰岛素敏感性指数、收缩压、平均血压和 WBC 计数呈正相关(P<0.05)。在调整年龄、性别、BMI、WBC 计数和收缩压后,HOMA-IR 指数仍与 YKL-40 水平显著相关(P<0.001)。研究表明,肥胖青少年的 YKL-40 水平升高,即使在儿童时期,也代表胰岛素抵抗的标志物。需要前瞻性研究来确定 YKL-40 水平升高的儿童是否未来患心血管疾病的风险更高。